WCN24-773 SPARSENTAN AS FIRST-LINE TREATMENT OF INCIDENT PATIENTS WITH IgA NEPHROPATHY: PRELIMINARY FINDINGS FROM THE SPARTAN TRIAL - Chee Kay Cheung; Stephanie Moody; Neeraj Dhaun; Siân Griffin; Alexandra Howson; Radko Komers; Alex Mercer; Matthew Sayer; Smeeta Sinha; Lisa Willcocks; Jonathan Barratt (Kidney International Reports)